SpyGlass Pharma SGP Cash Flow Statement (2024-2026)

NASDAQ SGP
$26.16 +1.56 (+6.34%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

SpyGlass Pharma Quarterly Cash Flow Statement

Periods 4 quarters
Latest Jun 2026

SpyGlass Pharma cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2024 Jun2025 Dec2025 Jun2026
Operating Activities
Net Income -8.68M-19.86M
Depreciation and DepletionDep. & Depletion 0.14M0.34M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.14M0.34M
Gains from Sales and DivestituresGains Divest 0.00M
Additional items
Ending Cash Balance 16.27M127.24M96.36M223.14M

SpyGlass Pharma Cash Flow Statement API

Pull SpyGlass Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SGP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY